nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—ALB—Erlotinib—kidney cancer	0.0478	1	CbGbCtD
Gadobenate Dimeglumine—Constipation—Vincristine—kidney cancer	0.000321	0.000337	CcSEcCtD
Gadobenate Dimeglumine—Pain in extremity—Doxorubicin—kidney cancer	0.000321	0.000337	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Gemcitabine—kidney cancer	0.00032	0.000336	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Capecitabine—kidney cancer	0.00032	0.000336	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Capecitabine—kidney cancer	0.00032	0.000336	CcSEcCtD
Gadobenate Dimeglumine—Cough—Paclitaxel—kidney cancer	0.000319	0.000335	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Sunitinib—kidney cancer	0.000319	0.000335	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Gemcitabine—kidney cancer	0.000318	0.000334	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Vinblastine—kidney cancer	0.000317	0.000333	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Gemcitabine—kidney cancer	0.000317	0.000333	CcSEcCtD
Gadobenate Dimeglumine—Migraine—Doxorubicin—kidney cancer	0.000316	0.000332	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Everolimus—kidney cancer	0.000316	0.000332	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Sorafenib—kidney cancer	0.000316	0.000332	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Paclitaxel—kidney cancer	0.000315	0.000331	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Sunitinib—kidney cancer	0.000314	0.00033	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Capecitabine—kidney cancer	0.000313	0.000328	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Capecitabine—kidney cancer	0.000311	0.000327	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Paclitaxel—kidney cancer	0.000311	0.000327	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Paclitaxel—kidney cancer	0.000311	0.000327	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Paclitaxel—kidney cancer	0.000311	0.000327	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Capecitabine—kidney cancer	0.00031	0.000326	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Paclitaxel—kidney cancer	0.00031	0.000326	CcSEcCtD
Gadobenate Dimeglumine—Face oedema—Doxorubicin—kidney cancer	0.00031	0.000325	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Dactinomycin—kidney cancer	0.00031	0.000325	CcSEcCtD
Gadobenate Dimeglumine—Chills—Capecitabine—kidney cancer	0.000309	0.000325	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000309	0.000324	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Capecitabine—kidney cancer	0.000308	0.000323	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000308	0.000323	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Paclitaxel—kidney cancer	0.000307	0.000323	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Gemcitabine—kidney cancer	0.000307	0.000323	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Vincristine—kidney cancer	0.000307	0.000322	CcSEcCtD
Gadobenate Dimeglumine—Cardiac arrest—Doxorubicin—kidney cancer	0.000305	0.000321	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Sorafenib—kidney cancer	0.000305	0.00032	CcSEcCtD
Gadobenate Dimeglumine—Pain—Gemcitabine—kidney cancer	0.000305	0.00032	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Gemcitabine—kidney cancer	0.000305	0.00032	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Erlotinib—kidney cancer	0.000305	0.00032	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Paclitaxel—kidney cancer	0.000304	0.00032	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Sunitinib—kidney cancer	0.000304	0.000319	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Capecitabine—kidney cancer	0.000302	0.000317	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Dactinomycin—kidney cancer	0.000302	0.000317	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Paclitaxel—kidney cancer	0.000301	0.000316	CcSEcCtD
Gadobenate Dimeglumine—Blood creatinine increased—Doxorubicin—kidney cancer	0.000301	0.000316	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Capecitabine—kidney cancer	0.0003	0.000315	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Capecitabine—kidney cancer	0.0003	0.000315	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Paclitaxel—kidney cancer	0.000298	0.000313	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Vincristine—kidney cancer	0.000297	0.000312	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Vincristine—kidney cancer	0.000297	0.000312	CcSEcCtD
Gadobenate Dimeglumine—Liver function test abnormal—Doxorubicin—kidney cancer	0.000296	0.000311	CcSEcCtD
Gadobenate Dimeglumine—Infection—Paclitaxel—kidney cancer	0.000296	0.000311	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Capecitabine—kidney cancer	0.000294	0.000308	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Sunitinib—kidney cancer	0.000294	0.000308	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Gemcitabine—kidney cancer	0.000294	0.000308	CcSEcCtD
Gadobenate Dimeglumine—Shock—Paclitaxel—kidney cancer	0.000293	0.000308	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Sorafenib—kidney cancer	0.000293	0.000308	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Paclitaxel—kidney cancer	0.000292	0.000307	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Paclitaxel—kidney cancer	0.000291	0.000306	CcSEcCtD
Gadobenate Dimeglumine—Rash—Sorafenib—kidney cancer	0.000291	0.000306	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Sorafenib—kidney cancer	0.000291	0.000305	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Capecitabine—kidney cancer	0.00029	0.000305	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Paclitaxel—kidney cancer	0.00029	0.000304	CcSEcCtD
Gadobenate Dimeglumine—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000289	0.000304	CcSEcCtD
Gadobenate Dimeglumine—Headache—Sorafenib—kidney cancer	0.000289	0.000304	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Capecitabine—kidney cancer	0.000288	0.000303	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Paclitaxel—kidney cancer	0.000288	0.000303	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Dactinomycin—kidney cancer	0.000288	0.000302	CcSEcCtD
Gadobenate Dimeglumine—Nasopharyngitis—Doxorubicin—kidney cancer	0.000287	0.000301	CcSEcCtD
Gadobenate Dimeglumine—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000283	0.000297	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Sunitinib—kidney cancer	0.000282	0.000296	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Gemcitabine—kidney cancer	0.000282	0.000296	CcSEcCtD
Gadobenate Dimeglumine—Tremor—Capecitabine—kidney cancer	0.000281	0.000295	CcSEcCtD
Gadobenate Dimeglumine—Rash—Sunitinib—kidney cancer	0.00028	0.000294	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Sunitinib—kidney cancer	0.00028	0.000294	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Paclitaxel—kidney cancer	0.000279	0.000293	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Capecitabine—kidney cancer	0.000278	0.000292	CcSEcCtD
Gadobenate Dimeglumine—Headache—Sunitinib—kidney cancer	0.000278	0.000292	CcSEcCtD
Gadobenate Dimeglumine—Asthma—Doxorubicin—kidney cancer	0.000277	0.000291	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Capecitabine—kidney cancer	0.000277	0.000291	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Vincristine—kidney cancer	0.000277	0.000291	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Sorafenib—kidney cancer	0.000274	0.000288	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000272	0.000285	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Capecitabine—kidney cancer	0.00027	0.000284	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Vincristine—kidney cancer	0.000269	0.000283	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Capecitabine—kidney cancer	0.000269	0.000282	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Capecitabine—kidney cancer	0.000268	0.000282	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Paclitaxel—kidney cancer	0.000268	0.000281	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Dactinomycin—kidney cancer	0.000267	0.000281	CcSEcCtD
Gadobenate Dimeglumine—Bronchitis—Doxorubicin—kidney cancer	0.000267	0.00028	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Paclitaxel—kidney cancer	0.000266	0.000279	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Paclitaxel—kidney cancer	0.000265	0.000278	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Capecitabine—kidney cancer	0.000265	0.000278	CcSEcCtD
Gadobenate Dimeglumine—Rash—Dactinomycin—kidney cancer	0.000265	0.000278	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Sunitinib—kidney cancer	0.000264	0.000277	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Capecitabine—kidney cancer	0.000264	0.000277	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Paclitaxel—kidney cancer	0.000263	0.000276	CcSEcCtD
Gadobenate Dimeglumine—Cough—Capecitabine—kidney cancer	0.000262	0.000275	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Capecitabine—kidney cancer	0.000259	0.000272	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000257	0.00027	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Paclitaxel—kidney cancer	0.000257	0.00027	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Vincristine—kidney cancer	0.000257	0.00027	CcSEcCtD
Gadobenate Dimeglumine—Pollakiuria—Doxorubicin—kidney cancer	0.000256	0.000269	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Gemcitabine—kidney cancer	0.000256	0.000268	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Capecitabine—kidney cancer	0.000255	0.000268	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Capecitabine—kidney cancer	0.000255	0.000268	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Capecitabine—kidney cancer	0.000255	0.000268	CcSEcCtD
Gadobenate Dimeglumine—Pain—Paclitaxel—kidney cancer	0.000255	0.000268	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Paclitaxel—kidney cancer	0.000255	0.000268	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Capecitabine—kidney cancer	0.000254	0.000267	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000254	0.000266	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Capecitabine—kidney cancer	0.000252	0.000265	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Gemcitabine—kidney cancer	0.000252	0.000265	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Doxorubicin—kidney cancer	0.00025	0.000263	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Capecitabine—kidney cancer	0.00025	0.000262	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Dactinomycin—kidney cancer	0.00025	0.000262	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Vincristine—kidney cancer	0.000248	0.000261	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Doxorubicin—kidney cancer	0.000247	0.00026	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Doxorubicin—kidney cancer	0.000247	0.00026	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Capecitabine—kidney cancer	0.000247	0.000259	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Paclitaxel—kidney cancer	0.000246	0.000258	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000244	0.000256	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Gemcitabine—kidney cancer	0.000244	0.000256	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Doxorubicin—kidney cancer	0.000243	0.000255	CcSEcCtD
Gadobenate Dimeglumine—Infection—Capecitabine—kidney cancer	0.000243	0.000255	CcSEcCtD
Gadobenate Dimeglumine—Shock—Capecitabine—kidney cancer	0.000241	0.000253	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Doxorubicin—kidney cancer	0.00024	0.000253	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Doxorubicin—kidney cancer	0.00024	0.000253	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Capecitabine—kidney cancer	0.00024	0.000252	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Capecitabine—kidney cancer	0.000239	0.000251	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Vincristine—kidney cancer	0.000239	0.000251	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Capecitabine—kidney cancer	0.000238	0.00025	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Doxorubicin—kidney cancer	0.000237	0.000249	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Paclitaxel—kidney cancer	0.000237	0.000249	CcSEcCtD
Gadobenate Dimeglumine—Rash—Vincristine—kidney cancer	0.000237	0.000249	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Capecitabine—kidney cancer	0.000237	0.000248	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Vincristine—kidney cancer	0.000237	0.000248	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Doxorubicin—kidney cancer	0.000236	0.000248	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Paclitaxel—kidney cancer	0.000236	0.000248	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Paclitaxel—kidney cancer	0.000236	0.000248	CcSEcCtD
Gadobenate Dimeglumine—Headache—Vincristine—kidney cancer	0.000235	0.000247	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Capecitabine—kidney cancer	0.000229	0.00024	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Gemcitabine—kidney cancer	0.000226	0.000238	CcSEcCtD
Gadobenate Dimeglumine—Bradycardia—Doxorubicin—kidney cancer	0.000226	0.000237	CcSEcCtD
Gadobenate Dimeglumine—Rash—Gemcitabine—kidney cancer	0.000225	0.000236	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Gemcitabine—kidney cancer	0.000224	0.000236	CcSEcCtD
Gadobenate Dimeglumine—Headache—Gemcitabine—kidney cancer	0.000223	0.000234	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Vincristine—kidney cancer	0.000223	0.000234	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000223	0.000234	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Doxorubicin—kidney cancer	0.000223	0.000234	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Doxorubicin—kidney cancer	0.000221	0.000232	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Capecitabine—kidney cancer	0.00022	0.000231	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Paclitaxel—kidney cancer	0.00022	0.000231	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Doxorubicin—kidney cancer	0.000219	0.00023	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Doxorubicin—kidney cancer	0.000219	0.00023	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Doxorubicin—kidney cancer	0.000218	0.000229	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Capecitabine—kidney cancer	0.000218	0.000229	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Doxorubicin—kidney cancer	0.000218	0.000229	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Capecitabine—kidney cancer	0.000215	0.000226	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Doxorubicin—kidney cancer	0.000214	0.000225	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Paclitaxel—kidney cancer	0.000214	0.000225	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Gemcitabine—kidney cancer	0.000212	0.000222	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000211	0.000222	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Capecitabine—kidney cancer	0.000211	0.000222	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Paclitaxel—kidney cancer	0.000211	0.000222	CcSEcCtD
Gadobenate Dimeglumine—Pain—Capecitabine—kidney cancer	0.000209	0.00022	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Capecitabine—kidney cancer	0.000209	0.00022	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Doxorubicin—kidney cancer	0.000208	0.000218	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Doxorubicin—kidney cancer	0.000207	0.000217	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Doxorubicin—kidney cancer	0.000206	0.000216	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Doxorubicin—kidney cancer	0.000206	0.000216	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Paclitaxel—kidney cancer	0.000204	0.000214	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Capecitabine—kidney cancer	0.000202	0.000212	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Doxorubicin—kidney cancer	0.000201	0.000212	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Doxorubicin—kidney cancer	0.000201	0.000211	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Capecitabine—kidney cancer	0.0002	0.00021	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Doxorubicin—kidney cancer	0.0002	0.00021	CcSEcCtD
Gadobenate Dimeglumine—Chills—Doxorubicin—kidney cancer	0.000199	0.000209	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Doxorubicin—kidney cancer	0.000198	0.000208	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Paclitaxel—kidney cancer	0.000197	0.000207	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Doxorubicin—kidney cancer	0.000195	0.000204	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Capecitabine—kidney cancer	0.000194	0.000204	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Capecitabine—kidney cancer	0.000193	0.000203	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Capecitabine—kidney cancer	0.000193	0.000203	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Doxorubicin—kidney cancer	0.000193	0.000203	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Doxorubicin—kidney cancer	0.000193	0.000203	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Paclitaxel—kidney cancer	0.00019	0.000199	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Doxorubicin—kidney cancer	0.000189	0.000199	CcSEcCtD
Gadobenate Dimeglumine—Rash—Paclitaxel—kidney cancer	0.000188	0.000197	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Paclitaxel—kidney cancer	0.000188	0.000197	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Doxorubicin—kidney cancer	0.000187	0.000196	CcSEcCtD
Gadobenate Dimeglumine—Headache—Paclitaxel—kidney cancer	0.000187	0.000196	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Doxorubicin—kidney cancer	0.000186	0.000195	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Capecitabine—kidney cancer	0.00018	0.000189	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Doxorubicin—kidney cancer	0.000179	0.000188	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Doxorubicin—kidney cancer	0.000179	0.000188	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Paclitaxel—kidney cancer	0.000177	0.000186	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Capecitabine—kidney cancer	0.000176	0.000184	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Doxorubicin—kidney cancer	0.000174	0.000183	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Doxorubicin—kidney cancer	0.000173	0.000182	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Capecitabine—kidney cancer	0.000173	0.000182	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Doxorubicin—kidney cancer	0.000173	0.000182	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Doxorubicin—kidney cancer	0.000171	0.000179	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Doxorubicin—kidney cancer	0.00017	0.000178	CcSEcCtD
Gadobenate Dimeglumine—Cough—Doxorubicin—kidney cancer	0.000169	0.000177	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Capecitabine—kidney cancer	0.000167	0.000176	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Doxorubicin—kidney cancer	0.000167	0.000175	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Doxorubicin—kidney cancer	0.000165	0.000173	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Doxorubicin—kidney cancer	0.000165	0.000173	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Doxorubicin—kidney cancer	0.000165	0.000173	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Doxorubicin—kidney cancer	0.000164	0.000172	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000163	0.000172	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Doxorubicin—kidney cancer	0.000163	0.000171	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Capecitabine—kidney cancer	0.000162	0.00017	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Doxorubicin—kidney cancer	0.000161	0.000169	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Doxorubicin—kidney cancer	0.000159	0.000167	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Doxorubicin—kidney cancer	0.000158	0.000166	CcSEcCtD
Gadobenate Dimeglumine—Infection—Doxorubicin—kidney cancer	0.000157	0.000165	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Capecitabine—kidney cancer	0.000156	0.000163	CcSEcCtD
Gadobenate Dimeglumine—Shock—Doxorubicin—kidney cancer	0.000155	0.000163	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Doxorubicin—kidney cancer	0.000155	0.000162	CcSEcCtD
Gadobenate Dimeglumine—Rash—Capecitabine—kidney cancer	0.000154	0.000162	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Capecitabine—kidney cancer	0.000154	0.000162	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Doxorubicin—kidney cancer	0.000154	0.000162	CcSEcCtD
Gadobenate Dimeglumine—Headache—Capecitabine—kidney cancer	0.000153	0.000161	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Doxorubicin—kidney cancer	0.000153	0.000161	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Doxorubicin—kidney cancer	0.000153	0.00016	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Doxorubicin—kidney cancer	0.000147	0.000155	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Capecitabine—kidney cancer	0.000145	0.000153	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000144	0.000151	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Doxorubicin—kidney cancer	0.000142	0.000149	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Doxorubicin—kidney cancer	0.000141	0.000148	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Doxorubicin—kidney cancer	0.00014	0.000147	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Doxorubicin—kidney cancer	0.000139	0.000146	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000136	0.000143	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Doxorubicin—kidney cancer	0.000136	0.000143	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Doxorubicin—kidney cancer	0.000135	0.000142	CcSEcCtD
Gadobenate Dimeglumine—Pain—Doxorubicin—kidney cancer	0.000135	0.000142	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Doxorubicin—kidney cancer	0.00013	0.000137	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000129	0.000135	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Doxorubicin—kidney cancer	0.000125	0.000132	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Doxorubicin—kidney cancer	0.000125	0.000131	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Doxorubicin—kidney cancer	0.000125	0.000131	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Doxorubicin—kidney cancer	0.000116	0.000122	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Doxorubicin—kidney cancer	0.000113	0.000119	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Doxorubicin—kidney cancer	0.000112	0.000117	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Doxorubicin—kidney cancer	0.000108	0.000113	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Doxorubicin—kidney cancer	0.000104	0.00011	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Doxorubicin—kidney cancer	0.0001	0.000105	CcSEcCtD
Gadobenate Dimeglumine—Rash—Doxorubicin—kidney cancer	9.95e-05	0.000104	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Doxorubicin—kidney cancer	9.94e-05	0.000104	CcSEcCtD
Gadobenate Dimeglumine—Headache—Doxorubicin—kidney cancer	9.88e-05	0.000104	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Doxorubicin—kidney cancer	9.37e-05	9.84e-05	CcSEcCtD
